Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2014 1
2015 3
2016 6
2017 11
2018 8
2019 14
2020 9
2021 17
2022 17
2023 21
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
ERS International Congress 2023: highlights from the Interstitial Lung Diseases Assembly.
Fabbri L, Guiot J, Vermant M, Miądlikowska E, Estrella D, Wijsenbeek MS, Wuyts W, Bargagli E, Froidure A, Spagnolo P, Veltkamp M, Molina-Molina M, McCarthy C, Antoniou K, Kreuter M, Moor CC. Fabbri L, et al. Among authors: wijsenbeek ms. ERJ Open Res. 2024 Mar 25;10(2):00839-2023. doi: 10.1183/23120541.00839-2023. eCollection 2024 Mar. ERJ Open Res. 2024. PMID: 38529351 Free PMC article.
Methotrexate Polyglutamate Concentrations as a Possible Predictive Marker for Effectiveness of Methotrexate Therapy in Patients with Sarcoidosis: A Pilot Study.
Janssen Bonás M, Sundaresan J, Keijsers RGM, Struys EA, Peters BJM, Kahlmann V, Wijsenbeek MS, de Rotte MCFJ, Grutters JC, Veltkamp M. Janssen Bonás M, et al. Among authors: wijsenbeek ms. Lung. 2023 Dec;201(6):617-624. doi: 10.1007/s00408-023-00656-0. Epub 2023 Nov 16. Lung. 2023. PMID: 37973683
Quality of life in sarcoidosis.
Moor CC, Obi ON, Kahlmann V, Buschulte K, Wijsenbeek MS. Moor CC, et al. Among authors: wijsenbeek ms. J Autoimmun. 2023 Oct 7:103123. doi: 10.1016/j.jaut.2023.103123. Online ahead of print. J Autoimmun. 2023. PMID: 37813805 Free article.
Pulmonary fibrosis: from pathogenesis to clinical decision-making.
Koudstaal T, Funke-Chambour M, Kreuter M, Molyneaux PL, Wijsenbeek MS. Koudstaal T, et al. Among authors: wijsenbeek ms. Trends Mol Med. 2023 Dec;29(12):1076-1087. doi: 10.1016/j.molmed.2023.08.010. Epub 2023 Sep 14. Trends Mol Med. 2023. PMID: 37716906 Review.
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD).
Maher TM, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM, Kreuter M, Oldham JM, Richeldi L, Valenzuela C, Wijsenbeek MS, Coeck C, Schlecker C, Voss F, Wachtlin D, Martinez FJ. Maher TM, et al. Among authors: wijsenbeek ms. BMJ Open Respir Res. 2023 Sep;10(1):e001580. doi: 10.1136/bmjresp-2022-001580. BMJ Open Respir Res. 2023. PMID: 37709661 Free PMC article. Clinical Trial.
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF).
Richeldi L, Azuma A, Cottin V, Kreuter M, Maher TM, Martinez FJ, Oldham JM, Valenzuela C, Gordat M, Liu Y, Stowasser S, Zoz DF, Wijsenbeek MS. Richeldi L, et al. Among authors: wijsenbeek ms. BMJ Open Respir Res. 2023 Aug;10(1):e001563. doi: 10.1136/bmjresp-2022-001563. BMJ Open Respir Res. 2023. PMID: 37597969 Free PMC article. Clinical Trial.
104 results